1. Home
  2. SOPA vs LIXT Comparison

SOPA vs LIXT Comparison

Compare SOPA & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Society Pass Incorporated

SOPA

Society Pass Incorporated

HOLD

Current Price

$2.22

Market Cap

23.0M

Sector

Technology

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.33

Market Cap

25.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPA
LIXT
Founded
2018
2005
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
25.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPA
LIXT
Price
$2.22
$3.33
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
15.0M
84.6K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,227,427.00
N/A
Revenue This Year
$2.43
N/A
Revenue Next Year
$71.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.65
N/A
52 Week Low
$0.64
$0.64
52 Week High
$6.75
$6.26

Technical Indicators

Market Signals
Indicator
SOPA
LIXT
Relative Strength Index (RSI) 48.34 42.48
Support Level $2.12 $3.04
Resistance Level $2.78 $3.53
Average True Range (ATR) 0.30 0.33
MACD -0.09 0.01
Stochastic Oscillator 8.05 43.92

Price Performance

Historical Comparison
SOPA
LIXT

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: